Patent · US Active

Midodrine hydrochloride oral solution and uses thereof

US11013702B2 · kind B2 · utility

0Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 10, 2018
Grant dateMay 25, 2021
Priority date—
Expiry dateDec 24, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P13/02
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides oral liquid midodrine formulation and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.